The gastrointestinal microbiota can effect the event of RA as a result of proximal intestinal immunomodulatory cells, which can be located in particular places throughout the intestine.The newest therapeutic method of RA permitted from the FDA and EMA will involve the use of JAKi. These molecules are divided into two teams based on their own select